Search research articles
Contact Us
Filters
Showing results (101-110 of 130) with videos related to
Page
of 13
Sort By:
Thrombosis Research
|
May 1, 1987
Measurement of heparin in plasma: influence of inter-subject and circadian variability in heparin sensitivity according to method
M F Scully, H A Decousus, V Ellis, et al.
Thrombosis and Haemostasis
|
April 1, 1997
Decrease in factor VII coagulant activity during percutaneous transluminal coronary angioplasty by heparin-mediated lipolytic action
M Mukherjee, M F Scully, V V Kakkar, et al.
Thrombosis and Haemostasis
|
May 1, 1996
Evidence for cultured human vascular smooth muscle cell heterogeneity: isolation of clonal cells and study of their growth characteristics
O Benzakour, C Kanthou, S M Kanse, et al.
The Journal of Biological Chemistry
|
March 5, 1993
In vitro and in vivo characterization of a neutral boron-containing thrombin inhibitor
C Tapparelli, R Metternich, C Ehrhardt, et al.
Lancet (London, England)
|
August 31, 1991
Late-onset homozygous protein C deficiency
C B Grundy, E Melissari, V Lindo, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Design of novel types of thrombin inhibitors based on modified D-Phe-Pro-Arg sequences
G Claeson, S Elgendy, L Cheng, et al.
British Journal of Haematology
|
April 1, 1982
An acquired coagulation inhibitor to factor II
M F Scully, V Ellis, V V Kakkar, et al.
FEBS Letters
|
August 11, 1997
Identification of a cyclic peptide inhibitor of platelet-derived growth factor-BB receptor-binding and mitogen-induced DNA synthesis in human fibroblasts
D M Brennand, U Dennehy, V Ellis, et al.
British Journal of Haematology
|
February 1, 1977
Acquired dysfibrinogenaemia in acute and chronic liver disease
D A Lane, M F Scully, D P Thomas, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
The use of isosteric bonds in the design of thrombin inhibitors
M F Scully, J Deadman, L Cheng, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 130) with videos related to
Sort By:
Page
of 13
Thrombosis Research
|
May 1, 1987
Measurement of heparin in plasma: influence of inter-subject and circadian variability in heparin sensitivity according to method
M F Scully, H A Decousus, V Ellis, et al.
Thrombosis and Haemostasis
|
April 1, 1997
Decrease in factor VII coagulant activity during percutaneous transluminal coronary angioplasty by heparin-mediated lipolytic action
M Mukherjee, M F Scully, V V Kakkar, et al.
Thrombosis and Haemostasis
|
May 1, 1996
Evidence for cultured human vascular smooth muscle cell heterogeneity: isolation of clonal cells and study of their growth characteristics
O Benzakour, C Kanthou, S M Kanse, et al.
The Journal of Biological Chemistry
|
March 5, 1993
In vitro and in vivo characterization of a neutral boron-containing thrombin inhibitor
C Tapparelli, R Metternich, C Ehrhardt, et al.
Lancet (London, England)
|
August 31, 1991
Late-onset homozygous protein C deficiency
C B Grundy, E Melissari, V Lindo, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Design of novel types of thrombin inhibitors based on modified D-Phe-Pro-Arg sequences
G Claeson, S Elgendy, L Cheng, et al.
British Journal of Haematology
|
April 1, 1982
An acquired coagulation inhibitor to factor II
M F Scully, V Ellis, V V Kakkar, et al.
FEBS Letters
|
August 11, 1997
Identification of a cyclic peptide inhibitor of platelet-derived growth factor-BB receptor-binding and mitogen-induced DNA synthesis in human fibroblasts
D M Brennand, U Dennehy, V Ellis, et al.
British Journal of Haematology
|
February 1, 1977
Acquired dysfibrinogenaemia in acute and chronic liver disease
D A Lane, M F Scully, D P Thomas, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
The use of isosteric bonds in the design of thrombin inhibitors
M F Scully, J Deadman, L Cheng, et al.
Page
of 13